scholarly journals A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

2020 ◽  
Vol 14 (7) ◽  
pp. e0008459 ◽  
Author(s):  
Federico Napolitano ◽  
Rossella Merone ◽  
Adele Abbate ◽  
Virginia Ammendola ◽  
Emma Horncastle ◽  
...  
2021 ◽  
Vol 15 (4) ◽  
pp. e0009348
Author(s):  
Federico Napolitano ◽  
Rossella Merone ◽  
Adele Abbate ◽  
Virginia Ammendola ◽  
Emma Horncastle ◽  
...  

2021 ◽  
Author(s):  
Sam Afkhami ◽  
Michael R. D'Agostino ◽  
Ali Zhang ◽  
Hannah D. Stacey ◽  
Art Marzok ◽  
...  

The emerging SARS-CoV-2 variants of concern (VOC) increasingly threaten the effectiveness of current first-generation COVID-19 vaccines that are administered intramuscularly and are designed to only target the spike protein. There is thus a pressing need to develop next-generation vaccine strategies to provide more broad and long-lasting protection. By using adenoviral vectors (Ad) of human and chimpanzee origin, we developed Ad-vectored trivalent COVID-19 vaccines expressing Spike-1, Nucleocapsid and RdRp antigens and evaluated them following single-dose intramuscular or intranasal immunization in murine models. We show that respiratory mucosal immunization, particularly with chimpanzee Ad-vectored vaccine, is superior to intramuscular immunization in induction of the three-arm immunity, consisting of local and systemic antibody responses, mucosal tissue-resident memory T cells, and mucosal trained innate immunity. We further show that single-dose intranasal immunization provides robust protection against not only the ancestral strain of SARS-CoV-2, but also two emerging VOC, B.1.1.7 and B.1.351. Our findings indicate that single-dose respiratory mucosal delivery of an Ad-vectored multivalent vaccine represents an effective next-generation COVID-19 vaccine strategy against current and future VOC. This strategy has great potential to be used not only to boost first-generation vaccine-induced immunity but also to expand the breadth of protective T cell immunity at the respiratory mucosa.


Toxins ◽  
2020 ◽  
Vol 12 (7) ◽  
pp. 432 ◽  
Author(s):  
Sam Woong Kim ◽  
Yeon Jo Ha ◽  
Kyu Ho Bang ◽  
Seungki Lee ◽  
Joo-Hong Yeo ◽  
...  

Bacteriocins are functionally diverse toxins produced by most microbes and are potent antimicrobial peptides (AMPs) for bacterial ghosts as next generation vaccines. Here, we first report that the AMPs secreted from Lactobacillus taiwanensis effectively form ghosts of pathogenic bacteria and are identified as diverse bacteriocins, including novel ones. In detail, a cell-free supernatant from L. taiwanensis exhibited antimicrobial activities against pathogenic bacteria and was observed to effectively cause cellular lysis through pore formation in the bacterial membrane using scanning electron microscopy (SEM). The treatment of the cell-free supernatant with proteinase K or EDTA proved that the antimicrobial activity is mediated by AMPs, and the purification of AMPs using Sep-Pak columns indicated that the cell-free supernatant includes various amphipathic peptides responsible for the antimicrobial activity. Furthermore, the whole-genome sequencing of L. taiwanensis revealed that the strain has diverse bacteriocins, confirmed experimentally to function as AMPs, and among them are three novel bacteriocins, designated as Tan 1, Tan 2, and Tan 3. We also confirmed, using SEM, that Tan 2 effectively produces bacterial ghosts. Therefore, our data suggest that the bacteriocins from L. taiwanensis are potentially useful as a critical component for the preparation of bacterial ghosts.


2011 ◽  
Vol 19 (1) ◽  
pp. 17-22 ◽  
Author(s):  
Shigefumi Okamoto ◽  
Hironori Yoshii ◽  
Masaaki Matsuura ◽  
Asato Kojima ◽  
Toyokazu Ishikawa ◽  
...  

ABSTRACTTo maintain immunity against Japanese encephalitis virus (JEV), a formalin-inactivated Japanese encephalitis (JE) vaccine should be administered several times. The repeated vaccination is not helpful in the case of a sudden outbreak of JEV or when urgent travel to a high-JEV-risk region is required; however, there are few single-injection JE vaccine options. In the present study, we investigated the efficacy of a single dose of a new effective JE virus-like particle preparation containing the JE envelope protein (JE-VLP). Although single administration with JE-VLP protected less than 50% of mice against lethal JEV infection, adding poly(γ-glutamic acid) nanoparticles (γ-PGA-NPs) or aluminum adjuvant (alum) to JE-VLP significantly protected more than 90% of the mice. A single injection of JE-VLP with either γ-PGA-NPs or alum induced a significantly greater anti-JEV neutralizing antibody titer than JE-VLP alone. The enhanced titers were maintained for more than 6 months, resulting in long-lasting protection of 90% of the immunized mice. Although the vaccine design needs further modification to reach 100% protection, a single dose of JE-VLP with γ-PGA-NPs may be a useful step in developing a next-generation vaccine to stop a JE outbreak or to immunize travelers or military personnel.


2020 ◽  
Vol 152 ◽  
pp. 535-545 ◽  
Author(s):  
Nidhi Gupta ◽  
Hansa Regar ◽  
Vijay Kumar Verma ◽  
Dhaneswar Prusty ◽  
Amit Mishra ◽  
...  

2015 ◽  
Vol 11 (5) ◽  
pp. 1261-1267 ◽  
Author(s):  
Muna F Abry ◽  
Kelvin M Kimenyi ◽  
Fred O Osowo ◽  
Willingtone O Odhiambo ◽  
Steven O Sewe ◽  
...  

TECHNOLOGY ◽  
2014 ◽  
Vol 02 (01) ◽  
pp. 1-12 ◽  
Author(s):  
Justin R. Adams ◽  
Surya K. Mallapragada

The search for improved vaccine adjuvants has intensified recently with the growing popularity of subunit vaccines. These vaccines can induce efficient antibody response and cellular immunity without the safety constraints of live vaccines, but must overcome their poor immunogenicity. Next-generation vaccine adjuvants offer several advantages over conventional adjuvants and can be rationally designed to meet the requirements of the antigen. This review analyzes current research in the field of vaccine adjuvant design, with an emphasis on polymeric vaccine adjuvants.


2003 ◽  
Vol 1257 ◽  
pp. 27-31 ◽  
Author(s):  
David E. Briles ◽  
Susan K. Hollingshead ◽  
Marilyn J. Crain ◽  
Bing Ren ◽  
Shaper Mirza ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document